< Back
EMWA Logo EMWA Logo
 

Douglas Fiebig

Company:
Trilogy Writing & Consulting GmbH
Qualification:
PhD
Leader background:
After 8 years in academic research (much of the time spent wading in rivers), Douglas was fortunate to chance upon a job advert that would launch his career in medical writing. It soon became clear to him that, in addition to keeping his feet dry, working as a medical writer was surely the most enjoyable way to earn a living using his scientific and linguistic skills. He has been involved in regulatory medical writing since 1996. Together with two partners, he took the plunge in 2002 and established Trilogy Writing & Consulting, a specialist medical writing company. Many years of writing pre- and post-submission documentation provide the inspiration for his EMWA workshops. Douglas served on the EMWA Professional Development Committee (EPDC) from 2009 - 2013.
Workshops:
Introduction to the Paediatric Investigation Plan Application
    Level: Advanced Area: Drug Development
    Code: DDA10a Duration: 03:30:00
The Investigator’s Brochure
    Level: Foundation Area: Drug Development
    Code: DDF2a Duration: 03:00:00
Risk Management Plans: Challenges and insights
    Level: Advanced Area: Drug Development
    Code: DDA20 Duration: 03:30:00
Summarising Clinical Efficacy Data for a New Drug Application
    Level: Advanced Area: Drug Development
    Code: DDA23 Duration: 03:30:00
Writing reimbursement submissions
    Level: Advanced Area: Drug Development
    Code: DDA25 Duration: 03:30:00
Post-submission Pharmacovigilance Writing: Interactions with Authorities and Impact on RMPs and PSURs
    Level: Advanced Area: Drug Development
    Code: DDA26 Duration: 03:30:00
Medical Writing Between Dossier Submission and Drug Approval
    Level: Advanced Area: Drug Development
    Code: DDA2b Duration: 03:30:00
Medical Writing for Biosimilars
    Level: Advanced Area: Drug Development
    Code: DDA27 Duration: 03:30:00
The Investigational Medicinal Product Dossier: Gateway to Introducing New Drugs in the European Union
    Level: Advanced Area: Drug Development
    Code: DDA28 Duration: 03:30:00
Medical Writing for Non-interventional and Database Studies
    Level: Advanced Area: Drug Development
    Code: DDA29 Duration: 03:30:00
Clinical Study Reports in Oncology
    Level: Advanced Area: Drug Development
    Code: DDA24a Duration: 03:30:00